Current management strategies for multidrug-resistant Gram-negative urinary tract infections, a focus on aminoglycosides monotherapy
Background: Urinary tract infections (UTI) are common, with increasing rates of multidrug resistant pathogens in some countries. Recent trials suggest efficacy of new beta-lactam beta-lactamase inhibitors compared to carbapenems, piperacillin-tazobactam, or quinolones for UTI; however, these newer d...
Saved in:
| Main Authors: | Iris Zohar, Yasmin Maor, Neta Shirin, Dafna Yahav |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | CMI Communications |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S295059092405039X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of aminoglycosides on survival rate and renal outcomes in patients with urosepsis: a multicenter retrospective study
by: David Rozenblat, et al.
Published: (2025-04-01) -
Antimicrobial Management of Urinary Tract Infections: Insights from a Tertiary Care Hospital in Oman
by: Pranjal N. Chhajlani, et al.
Published: (2025-01-01) -
Turbidimetric Method for Standardization and Quality Control of Aminoglycoside Antibiotics and Aminoglycoside-Based Products
by: Yu. V. Olefir, et al.
Published: (2020-05-01) -
Investigation of Molecular Mechanisms of Aminoglycoside Resistance in Salmonella
by: A. V. Zubritskiy, et al.
Published: (2020-05-01) -
Aminoglycoside-induced balance deficits: A review of vestibulotoxicity
by: C. Rogers, et al.
Published: (2011-10-01)